EUVIMEDEUVIMED entdecken
Open Access

Anticoagulant Prophylaxis with Edoxaban for Asymptomatic Isolated Distal Deep Vein Thrombosis in Perioperative Hip Fracture Patients

Nozomu Ishikawa, Naoto Yamamoto, Tatsuro Yata, Takafumi Kayama, Yuta Yamanaka, Kazunori Inuzuka, Masaki Sano, Kazuto Katahashi, Hajime Tsuyuki, Yusuke Endo, Hiroya Takeuchi, Naoki Unno

Annals of Vascular Diseases · 2026 · 19 (1) · n/a

DOI: 10.3400/avd.oa.26-00179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Vascular Diseases, 2026. Verfasst von Nozomu Ishikawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, Hamamatsu Medical Center, Hamamatsu, Shizuoka, Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most distal deep vein thrombosis (DVT) presents a low risk of central progression and pulmonary thromboembolism (PTE), and uniform anticoagulation is not recommended. However, the perioperative period of hip fracture (HF) is associated with a high risk of DVT progression, but a therapeutic dose of anticoagulation raises concern about bleeding risk. There is no clear recommendation for anticoagulation for asymptomatic distal DVT during the perioperative period of HF. We retrospectively evaluated the appropriateness of general anticoagulant prophylaxis with edoxaban. From April 2017 to September 2022, among patients who underwent HF surgery at our hospital, 74 consecutive cases who were diagnosed with asymptomatic distal DVT were examined. Of the 52 cases receiving anticoagulant prophylaxis with edoxaban, 23 received the prophylactic standard dose (30 mg), and 29 received the prophylactic lower dose (15 mg). The duration of anticoagulation ranged from 5 to 28 days, with a median of 14 days. There were no recurrences of symptomatic venous thromboembolism (VTE) within 3 months after starting anticoagulation. This study suggests that a general perioperative prophylactic dose, rather than a therapeutic dose, can effectively suppress symptomatic VTE and enhance safety in patients with asymptomatic distal DVT developed during the perioperative period of HF. (This is a translation of Jpn J Phlebol 2025; 36: 33-38.).

Schlagwörter

Stichwörter der Autor:innen

deep vein thrombosisdirect oral anticoagulant (DOAC)hip fracturevenous thromboembolism

Autor:innen und Institutionen

  • Division of Vascular Surgery, Hamamatsu Medical Center, Hamamatsu, Shizuoka, Japan.
  • Division of Vascular Surgery, Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Zitieren

APA

Ishikawa, N., Yamamoto, N., Yata, T., Kayama, T., Yamanaka, Y., Inuzuka, K., Sano, M., Katahashi, K., Tsuyuki, H., Endo, Y., Takeuchi, H., & Unno, N. (2026). Anticoagulant Prophylaxis with Edoxaban for Asymptomatic Isolated Distal Deep Vein Thrombosis in Perioperative Hip Fracture Patients. Annals of Vascular Diseases, 19(1), n/a. https://doi.org/10.3400/avd.oa.26-00179

Vancouver

Ishikawa N, Yamamoto N, Yata T, Kayama T, Yamanaka Y, Inuzuka K, et al. Anticoagulant Prophylaxis with Edoxaban for Asymptomatic Isolated Distal Deep Vein Thrombosis in Perioperative Hip Fracture Patients. Annals of Vascular Diseases. 2026;19(1):n/a. doi:10.3400/avd.oa.26-00179

BibTeX
@article{Ishikawa2026,
  author = {Ishikawa, Nozomu and Yamamoto, Naoto and Yata, Tatsuro and Kayama, Takafumi and Yamanaka, Yuta and Inuzuka, Kazunori and Sano, Masaki and Katahashi, Kazuto and Tsuyuki, Hajime and Endo, Yusuke and Takeuchi, Hiroya and Unno, Naoki},
  title = {Anticoagulant Prophylaxis with Edoxaban for Asymptomatic Isolated Distal Deep Vein Thrombosis in Perioperative Hip Fracture Patients},
  journal = {Annals of Vascular Diseases},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {n/a},
  doi = {10.3400/avd.oa.26-00179}
}
Kostenlos starten →